Research & Development



  “我找甦稚給我開消腫的藥……”   “再有十天,劉陵將抵達藍氏城。”伊人在线猫   以為成法可以在秦國本土執行,就能在六國之地執行,卻不知楚人爛漫,齊人懶惰,趙人彪悍,燕人詭詐,韓人得過且過,魏人還活在祖宗的榮光里。大香蕉网伊人在线4   他第一次離開父親跟隨的將軍就是霍去病,他跟著霍去病,雲瑯參加了無數次戰斗……   “光屁股面對人的時候,我們總會不由自主的去揣摩那家伙看到我的光屁股會怎麼想。這時候,只要是人,就會下意識的遮掩一下羞處。當我光著屁股面對一群豬,或者羊,或者狗的時候,你覺得我有遮掩羞處的必要嗎?”五月婷婷久久大香蕉   雲瑯搖晃著手里的蘆葦頭道︰“還需要安排四到六個侍女,每個侍女的皮膚要白皙,身材要各不相同,從肥的到瘦的一個都不能缺。這方便阿襄寂寞的時候散心。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo